We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
New heteroleptic lanthanide complexes as multimodal drugs: Cytotoxicity studies, apoptosis, cell cycle analysis, DNA interactions, and protein binding.
- Authors
Munteanu, Alexandra‐Cristina; Musat, Mihaela Georgiana; Mihaila, Mirela; Badea, Mihaela; Olar, Rodica; Nitulescu, George Mihai; Rădulescu, Flavian Ștefan; Brasoveanu, Lorelei Irina; Uivarosi, Valentina
- Abstract
We report herein the synthesis and characterization of four new heteroleptic complexes of Sm(III), Eu(III), Gd(III), and Tb(III) with the natural flavonoid 5‐hydroxyflavone (primuletin) and 1,10‐phenanthroline. According to the physicochemical characterization, the mononuclear complexes correspond to the general formula [Ln(OH)2L1L2]·nH2O, where L1 = C15H9O3 (deprotonated 5‐hydroxyflavone) and L2 = C12H8N2 (1,10‐phenanthroline), Ln is the lanthanide cation, and n = 4 for Sm(III), 3.5 for Eu(III), 2 for Gd(III), and 3 for Tb(III). A six‐coordinated distorted octahedron geometry was proposed for the complexes, and density functional theory (DFT) studies were used to calculate their optimized geometry. Cytotoxicity was studied using MTS assay on cervical, colorectal, colon, breast, and ovarian adenocarcinoma cell lines. Flow cytometry data were consistent with apoptotic cell death and disruption of the cell cycle in cervical and colon cancer cells. As a means to investigate the mechanism underlying the cytotoxic effects, the abilities of the complexes to interact with calf thymus DNA, human serum albumin, and transferrin have also been assessed. According to experimental and computational studies, the four lanthanide complexes act as DNA intercalators and bind strongly to serum proteins.
- Subjects
CELL cycle; CELL analysis; PROTEIN binding; BLOOD proteins; DNA
- Publication
Applied Organometallic Chemistry, 2021, Vol 35, Issue 1, p1
- ISSN
0268-2605
- Publication type
Article
- DOI
10.1002/aoc.6062